Global Hashimoto’s Thyroiditis Drug Market is driven by...

added article Health

2024-04-24 10:41:42 -

Global Hashimoto’s Thyroiditis Drug Market is driven by rising prevalence of hypothyroidism disorders

The Global Hashimoto’s Thyroiditis Drug Market is estimated to be valued at US$ 2.18 BN in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period from 2024 to 2031. Key Takeaways Key players operating in the Global Hashimoto’s Thyroiditis Drug Market are AbbVie Inc., Merck & Co., Allergan., Amneal Pharmaceuticals., Lannett Company, Mylan Pharmaceuticals, Pfizer,...

0 Comments 0 Shares 1350 Views 0 Reviews